Galafold savings card: as little as $0 a month with commercial insurance

How to pay the least

Ask for the cash price

Galafold

We didn’t find one.

Ask your pharmacy for Galafold’s cash price, and one or two other pharmacies too.
Galafold’s savings card works only with insurance from a job or one you bought.

Compare every option

Brand nameGalafold

Authorized genericmigalastat

Regular genericmigalastat

What you’d pay

Cash priceAsk the pharmacy

Not soldThere isn’t one

Not soldNone found

Same as Galafold?

The original

–

Brand nameThe maker’s card

AMICUS ASSIST Co-Pay Assistance

Savings card from Amicus Therapeutics (a BioMarin company)

No insuranceNeeds insuranceNo cash price listed.

Insurance · as little as $0 a month

In the maker’s words

“Eligible, commercially insured patients may pay as little as $0 per month for Galafold…”

From the maker’s offer on galafold.com, checked November 2, 2026. Co-pay cards can’t be used with Medicare (including Medicare Advantage), Medicaid, TRICARE or VA.

Maker’s card or discount card?

A discount card like GoodRx lowers the pharmacy’s cash price, but for a brand-name drug that price often stays high. Compare it with the maker’s card above. You can usually use one or the other on a fill, not both.

Authorized genericNot sold

There isn’t one. An authorized generic is Galafold itself, from the same company, sold without the brand name, and usually for less. For now Galafold is the only choice; its maker’s savings card can lower what you pay.

See the brand name →

Regular genericNot sold

We didn’t find one. Generics usually come once the brand’s patents and exclusivity end. Until then, the maker’s savings card is the way to pay less.

See the brand name →

What it’s used for

Fabry disease with certain GLA gene changes

What the FDA label says

GALAFOLD is an alpha-galactosidase A (alpha-Gal A) pharmacological chaperone indicated for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene (GLA) variant based on in vitro assay data.

This indication is approved under accelerated approval based on reduction in kidney interstitial capillary cell globotriaosylceramide (KIC GL-3) substrate. Continued approval for this indication may be contingent upon verification and description of clinical benefit in confirmatory trials.

Source: the FDA label for Galafold (Amicus Therapeutics US, LLC), August 28, 2025. Full label on DailyMed

Good to know

“Commercial insurance” means a plan from a job, from the marketplace, or one you buy yourself. A retiree plan that’s part of Medicare counts as Medicare. Co-pay cards can’t be used with Medicare (including Medicare Advantage), Medicaid, TRICARE or VA.
Most cards need a sign-up on the maker’s site, and many work only if your plan covers the drug. Then give the card’s details to your pharmacy.
Don’t stop or change a medicine without talking to your pharmacist or prescriber.

Prices checked November 2, 2026. Prices change: confirm with the pharmacy before you fill. drugalt.com/drug/galafold/